GlaxoSmithKline S.A.E.EGX: BIOC

Glaxosmithkline Q3 Consol Loss EGP 34.8 Million

· Issued by GlaxoSmithKline S.A.E.

On 6ix: 6ix.com/news/glaxosmithkline-q3-consol-loss-egp-34.8-million

GLAXOSMITHKLINE SAE EGX:BIOC:

  • GLAXOSMITHKLINE Q3 CONSOL NET LOSS ATTRIBUTABLE EGP 34.8 MILLION

  • GLAXOSMITHKLINE Q3 CONSOL NET SALES EGP 1.01 BILLION

GlaxoSmithKline S.A.E. on 6ix

Later from GlaxoSmithKline S.A.E

All GlaxoSmithKline S.A.E news releases